There were 2,162 press releases posted in the last 24 hours and 429,010 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Opthea Completes Successful Meetings with FDA and EMA for OPT-302 Phase 3 Clinical Program in Wet AMD

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image